repository
BROWSE
Cited 0 times in 
Erratum: Osimertinib for patients with non–small-cell lung cancer harboring uncommon EGFR mutations: A multicenter, open-label, phase II trial (KCSG-LU15-09) (Journal of Clinical Oncology (2020) DOI: 10.1200/JCO.19.00931)
- Authors
- Cho, JH | Lim, SH | An, HJ | Kim, KH | Park, KU | Kang, EJ | Choi, YH | Ahn, MS | Lee, MH | Sun, JM | Lee, SH | Ahn, JS | Park, K | Ahn, MJ
- Citation
- Journal of clinical oncology, 38(11). : 1248-1248, 2020
- Journal Title
- Journal of clinical oncology
- ISSN
- 0732-183X1527-7755
- Abstract
- The February 10, 2020, article by Cho et al, entitled “Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)” (J Clin Oncol 10.1200/JCO.19.00931), was published with an error.
- Appears in Collections:
- Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
- Ajou Authors
- 안, 미선
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
